Embedded Files
Data Bridge Market Research analyses that the global genome editing market, which was USD 5,512.13 million in 2022, is expected to reach USD 18,400.23 million by 2030 and is expected to undergo a CAGR of 17.2% during the forecast period of 2023 to 2030. "CRISPR" dominates the technology segment of the global genome editing market due to the rising demand for genome editing. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market research analysis data included in this report lend a hand to businesses for planning of strategies related to investment, revenue generation, production, product launches, costing, inventory, purchasing and marketing. What's more Genome Editing Market report presents the data and information for actionable, most recent and real-time market insights which makes it easier to even take critical business decisions.
Download Copy of this Report to understand structure of the complete @ https://www.databridgemarketresearch.com/reports/global-genome-editing-market
Market Definition:
Genome editing is a technique for precisely altering an organism's or cell's DNA. It is used to alter any organism's genome. It uses a special kind of enzyme called an "engineered nuclease" that makes a precise cut in the genome. A specific region of the DNA is cut, and the cell automatically heals the damage. It has uses in various fields, including agriculture, biotechnology, medicines, and mutation. The prevalence of chronic and infectious diseases will probably increase, broadening the application of genome editing.
Market Overview:
Genome editing is a relatively new technique for changing specific DNA sequences. It has become common practice in fundamental biomedical research to examine gene function by modifying genomes using the bacterial immune system, a potent tool for genome editing. This technology is increasingly used in studying and treating human diseases by altering human blood cells injected into the body to cure various diseases, such as cystic fibrosis, cancer, and AIDS.
Market Scope and Size:
The global genome editing market is segmented on the basis of technology, application, product and service, method, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Technology
CRISPR
TALEN
ZFN
ANTISENSE
Other Technologies
Application
Cell Line Engineering
Genetic Engineering
Diagnostic Applications
Drug Discovery and Development
Other Applications
Product and Service
Reagents
Consumables
End User
Pharmaceutical and Biopharmaceutical Industry
Biotechnology Industry
Academic Institutions
CROs
Government Research Organizations
Others
Method
Ex-Vivo
In-Vivo
Country Level Analysis:
The countries covered in the global genome editing market report are U.S., Canada and Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina, and rest of South America as part of South America.
Key Players:
Some of the major players operating in the global genome editing market are:
· Merck KGaA (Germany)
· GenScript (China)
· Sangamo Therapeutics (U.S.)
· Lonza (Switzerland)
· Editas Medicine (U.S.)
· CRISPR Therapeutics (Switzerland)
· Tecan Trading AG (Switzerland)
· Precision Biosciences (U.S.)
· PerkinElmer Inc. (U.S.)
· Cellectis S.A (France)
· Genome Medical, Inc. (U.S.)
· BioMed Central Ltd (U.K.)
· Aevi Genomic Medicine, Inc. (Israel)
· Congenica Ltd. (U.K.)
· Deep Genomics (Canada)
· Editas Medicine (U.S.)
· Illumina, Inc. (U.S.)
· Thermo Fisher Scientific Inc. (U.S.)
Download Sample PDF Copy of this Report to understand structure of the complete report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-genome-editing-market
TABLE OF CONTENTS:
Part 01: Executive Summary
Part 02: Scope of the Report
Part 03: Research Methodology
Part 04: Market Landscape
Part 05: Pipeline Analysis
Part 06: Market Sizing
Continue………
Browse Trending Reports:
· Global Precision Medicine Market
· Global Traumatic Brain Injuries Treatment Market
About Data Bridge Market Research:
An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are committed to uncovering the best market opportunities and nurturing effective information for your business to thrive in the marketplace. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a set of pure wisdom and experience that was formulated and framed in 2015 in Pune.
Data Bridge Market Research has more than 500 analysts working in different industries. We have served more than 40% of the Fortune 500 companies globally and have a network of more than 5,000 clients worldwide. Data Bridge is an expert in creating satisfied customers who trust our services and trust our hard work with certainty. We are pleased with our glorious 99.9% customer satisfaction rating.
Contact Us: -
Data Bridge Market Research
US: +1 888 387 2818
United Kingdom: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: – corporatesales@databridgemarketresearch.com
Page updated
Google Sites
Report abuse